Adriana Marques

Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.

Evaluation of a new culture medium for Borrelia burgdorferi.

Lyme disease: an update.

Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine.

Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders.

C6 test as an indicator of therapy outcome for patients with localized or disseminated lyme borreliosis.

Audiologic manifestations of patients with post-treatment Lyme disease syndrome.

Research opportunities on human neuroborreliosis.

Detection of immune complexes is not independent of detection of antibodies in Lyme disease patients and does not confirm active infection with Borrelia burgdorferi.

Borrelia burgdorferi lipoprotein-mediated TLR2 stimulation causes the down-regulation of TLR5 in human monocytes.

Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early lyme encephalitis.

Role of interleukin 10 during persistent infection with the relapsing fever Spirochete Borrelia turicatae.

Chronic Lyme disease: a review.

IL-10 helps control pathogen load during high-level bacteremia.

Relapsing fever borreliosis in interleukin-10-deficient mice.

Interleukin 10 protects the brain microcirculation from spirochetal injury.

Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls.

Tick-borne relapsing fever and Borrelia hermsii, Los Angeles County, California, USA.

Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers.

Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease.

Lyme disease: a review.

Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome.

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.

Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease.

Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome.

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

Lack of serum antibodies against Borrelia burgdorferi in children with autism.

Treatment trials for post-Lyme disease symptoms revisited.

The reply.

Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases.

Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study.

Invariant natural killer T cells act as an extravascular cytotoxic barrier for joint-invading Lyme Borrelia.

Laboratory diagnosis of Lyme disease: advances and challenges.

Association of immune response to endothelial cell growth factor with early disseminated and late manifestations of Lyme disease but not posttreatment Lyme disease syndrome.

Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.

Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life Measures.

Insights into Borrelia miyamotoi infection from an untreated case demonstrating relapsing fever, monocytosis and a positive C6 Lyme serology.

Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.

Reply to Naktin.

Early Disseminated Lyme Disease Causing False-Positive Serology for Primary Epstein-Barr Virus Infection: Report of 2 Cases.

Citrate Anticoagulant Improves the Sensitivity of Borreliella (Borrelia) burgdorferi Plasma Culture.

Xenodiagnosis Using Ixodes scapularis Larval Ticks in Humans.

Transcriptome Assessment of Erythema Migrans Skin Lesions in Patients With Early Lyme Disease Reveals Predominant Interferon Signaling.

Advances in Serodiagnostic Testing for Lyme Disease Are at Hand.

A multiplex serologic platform for diagnosis of tick-borne diseases.

Plasticity in early immune evasion strategies of a bacterial pathogen.

C-Reactive Protein Response in Patients With Post-Treatment Lyme Disease Symptoms Versus Those With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Revisiting the Lyme Disease Serodiagnostic Algorithm: the Momentum Gathers.

Direct Diagnostic Tests for Lyme Disease.

Usefulness of Routine Lyme Screening in Patients with Uveitis.

A Multiplexed Serologic Test for Diagnosis of Lyme Disease for Point-of-Care Use.

Protective Immunity and New Vaccines for Lyme Disease.

Identification of immunoreactive linear epitopes of Borrelia miyamotoi.

Post-treatment Lyme disease symptoms score: Developing a new tool for research.

Characterization of a Monanema nematode in Ixodes scapularis.

Corrigendum to: Transcriptome Assessment of Erythema Migrans Skin Lesions in Patients With Early Lyme Disease Reveals Predominant Interferon Signaling.

Development of a capture sequencing assay for enhanced detection and genotyping of tick-borne pathogens.

Comparison of Lyme Disease in the United States and Europe.

Lack of Convincing Evidence That Borrelia burgdorferi Infection Causes Either Alzheimer Disease or Lewy Body Dementia.

Characteristics and outcome of facial nerve palsy from Lyme neuroborreliosis in the United States.

A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings.

Detection of antibodies to Anaplasma phagocytophilum and Babesia microti using linear peptides.

Persistent Symptoms After Treatment of Lyme Disease.

A Longitudinal Study of COVID-19 Sequelae and Immunity.

Pediatric Lyme disease: systematic assessment of post-treatment symptoms and quality of life.

Reply to Correspondence.